Imagion Biosystems Limited
Research Imagion Biosystems Limited (IBX.AX) on Bullrun: market cap AUD 4.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIBX.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 4.01M
- Financial periodFY2025
- Net income-AUD 4.31M
- Free cash flow-AUD 4.04M
Valuation Snapshot
latest market cap is AUD 4.01M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | -AUD 4.31M | -AUD 4.04M | n/a | -0.02 | AUD 1.85M | AUD 2.56M | -AUD 2.16M |
| FY2024 | AUD 1.16M | -AUD 2.07M | -AUD 1.27M | 100.0% | -0.05 | AUD 2.67M | AUD 2.65M | -AUD 2.28M |
| FY2023 | AUD 1.37M | -AUD 13.07M | -AUD 8.51M | 100.0% | -0.43 | AUD 227.08K | AUD 7.14M | -AUD 4.69M |
| FY2022 | AUD 473.43K | -AUD 9.81M | -AUD 8.58M | 100.0% | -0.35 | AUD 4.45M | AUD 4.60M | AUD 4.68M |
| FY2021 | AUD 232.87K | n/a | n/a | 100.0% | n/a | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 4.01M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Imagion Biosystems Limited
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Imagion Biosystems Limited's market cap?
Imagion Biosystems Limited's market capitalization is AUD 4.01M.
What does Imagion Biosystems Limited do?
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry.